Investigation of the marine sponge Agelas dispar MeOH fractions using feature-based molecular
networking, dereplication,
and isolation led to the discovery of new bromopyrrole-derived metabolites.
An in-house library of bromopyrrole alkaloids previously isolated
from A. dispar and Dictyonella sp.
was utilized, along with the investigation of an MS/MS fragmentation
of these compounds. Our strategy led to the isolation and identification
of the disparamides A–C (1–3), with a novel carbon skeleton. Additionally, new dispyrins B–F
(4–8) and nagelamides H2 and H3 (9 and 10) and known nagelamide H (11), citrinamine B (12), ageliferin (13),
bromoageliferin (14), and dibromoageliferin (15) were also isolated and identified by analysis of spectroscopic
data. Analysis of MS/MS fragmentation data and molecular networking
analysis indicated the presence of hymenidin (16), oroidin
(17), dispacamide (18), monobromodispacamide
(19), keramadine (20), longamide B (21), methyl ester of longamide B (22), hanishin
(23), methyl ester of 3-debromolongamide B (24), and 3-debromohanishin (25). Antibacterial activity
of ageliferin (13), bromoageliferin (14),
and dibromoageliferin (15) was evaluated against susceptible
and multi-drug-resistant ESKAPE pathogenic bacteria Klabsiella
pneumoniae, Escherichia coli, Staphylococcus
aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterococcus faecalis. Dibromoageliferin (15) displayed the most potent antimicrobial
activity against all tested susceptible and MDR strains. Compounds 13–15 presented no significant hemolytic
activity up to 100 μM.